These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 17318504

  • 1. Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study.
    Eser D, Schüle C, Baghai T, Floesser A, Krebs-Brown A, Enunwa M, de la Motte S, Engel R, Kucher K, Rupprecht R.
    Psychopharmacology (Berl); 2007 Jul; 192(4):479-87. PubMed ID: 17318504
    [Abstract] [Full Text] [Related]

  • 2. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
    Eser D, Leicht G, Baghai T, Pogarell O, Schüle C, Karch S, Nothdurfter C, Rupprecht R, Mulert C.
    J Psychiatr Res; 2009 Jan; 43(4):393-400. PubMed ID: 18534623
    [Abstract] [Full Text] [Related]

  • 3. Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.
    Koszycki D, Zacharko RM, Le Mellédo JM, Bradwejn J.
    Depress Anxiety; 1998 Jan; 8(1):1-7. PubMed ID: 9750972
    [Abstract] [Full Text] [Related]

  • 4. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
    Zwanzger P, Eser D, Völkel N, Baghai TC, Möller HJ, Rupprecht R, Padberg F.
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):285-9. PubMed ID: 16817979
    [Abstract] [Full Text] [Related]

  • 5. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
    Zwanzger P, Baghai TC, Schuele C, Ströhle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2001 Nov; 25(5):699-703. PubMed ID: 11682253
    [Abstract] [Full Text] [Related]

  • 6. Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects.
    Zwanzger P, Zavorotnyy M, Gencheva E, Diemer J, Kugel H, Heindel W, Ruland T, Ohrmann P, Arolt V, Domschke K, Pfleiderer B.
    Neuropsychopharmacology; 2013 Aug; 38(9):1648-54. PubMed ID: 23463151
    [Abstract] [Full Text] [Related]

  • 7. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    World J Biol Psychiatry; 2012 Oct; 13(7):526-34. PubMed ID: 22111662
    [Abstract] [Full Text] [Related]

  • 8. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P, Eser D, Aicher S, Schüle C, Baghai TC, Padberg F, Ella R, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A, Holsboer F, Rupprecht R.
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [Abstract] [Full Text] [Related]

  • 11. Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects.
    Flint AJ, Koszycki D, Bradwejn J, Vaccarino FJ.
    Psychoneuroendocrinology; 2000 Aug; 25(6):633-47. PubMed ID: 10840174
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
    Wiedemann K, Jahn H, Yassouridis A, Kellner M.
    Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
    [Abstract] [Full Text] [Related]

  • 14. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ, Jahn H, Goedeken B, Gescher DM, Kellner M, Wiedemann K.
    Depress Anxiety; 2006 Apr; 23(3):139-44. PubMed ID: 16470820
    [Abstract] [Full Text] [Related]

  • 15. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, Rupprecht R, Romeo E.
    Neuropsychopharmacology; 2005 Jan; 30(1):192-5. PubMed ID: 15467707
    [Abstract] [Full Text] [Related]

  • 16. Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.
    Kellner M, Muhtz C, Stark K, Yassouridis A, Arlt J, Wiedemann K.
    Psychopharmacology (Berl); 2005 Apr; 179(1):310-5. PubMed ID: 15821951
    [Abstract] [Full Text] [Related]

  • 17. Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.
    Tõru I, Aluoja A, Võhma U, Raag M, Vasar V, Maron E, Shlik J.
    Psychiatry Res; 2010 Jul 30; 178(2):342-7. PubMed ID: 20471107
    [Abstract] [Full Text] [Related]

  • 18. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K, Yassouridis A, Mass R, Tenge H, Kellner M, Jahn H, Wiedemann K, Wolf K.
    J Psychiatr Res; 2010 Dec 30; 44(16):1148-53. PubMed ID: 20451215
    [Abstract] [Full Text] [Related]

  • 19. Impact of state and trait anxiety on the panic response to CCK-4.
    Eser D, Wenninger S, Baghai T, Schüle C, Rupprecht R.
    J Neural Transm (Vienna); 2008 Jun 30; 115(6):917-20. PubMed ID: 18414777
    [Abstract] [Full Text] [Related]

  • 20. Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
    Zwanzger P, Eser D, Padberg F, Baghai TC, Schule C, Rötzer F, Ella R, Möller HJ, Rupprecht R.
    Depress Anxiety; 2003 Jun 30; 18(3):140-3. PubMed ID: 14625878
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.